Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.
paper
Primary
Public
- Authors
- Saccone, Nancy L; Culverhouse, Robert C; Schwantes-An, Tae-Hwi; Cannon, Dale S; Chen, Xiangning; Cichon, Sven; Giegling, Ina; Han, Shizhong; Han, Younghun; Keskitalo-Vuokko, Kaisu; Kong, Xiangyang; Landi, Maria Teresa; Ma, Jennie Z; Short, Susan E; Stephens, Sarah H; Stevens, Victoria L; Sun, Lingwei; Wang, Yufei; Wenzlaff, Angela S; Aggen, Steven H; Breslau, Naomi; Broderick, Peter; Chatterjee, Nilanjan; Chen, Jingchun; Heath, Andrew C; HeliΓΆvaara, Markku; Hoft, Nicole R; Hunter, David J; Jensen, Majken K; Martin, Nicholas G; Montgomery, Grant W; Niu, Tianhua; Payne, Thomas J; Peltonen, Leena; Pergadia, Michele L; Rice, John P; Sherva, Richard; Spitz, Margaret R; Sun, Juzhong; Wang, Jen C; Weiss, Robert B; Wheeler, William; Witt, Stephanie H; Yang, Bao-Zhu; Caporaso, Neil E; Ehringer, Marissa A; Eisen, Tim; Gapstur, Susan M; Gelernter, Joel; Houlston, Richard; Kaprio, Jaakko; Kendler, Kenneth S; Kraft, Peter; Leppert, Mark F; Li, Ming D; Madden, Pamela A F; NΓΆthen, Markus M; Pillai, Sreekumar; Rietschel, Marcella; Rujescu, Dan; Schwartz, Ann; Amos, Christopher I; Bierut, Laura J
- Year
- 2010
- Journal
- PLoS genetics
- PMID
- 20700436
- DOI
- 10.1371/journal.pgen.1001053
- PMCID
- PMC2916847
Recently, genetic association findings for nicotine dependence, smoking behavior, and smoking-related diseases converged to implicate the chromosome 15q25.1 region, which includes the CHRNA5-CHRNA3-CHRNB4 cholinergic nicotinic receptor subunit genes. In particular, association with the nonsynonymous CHRNA5 SNP rs16969968 and correlates has been replicated in several independent studies. Extensive genotyping of this region has suggested additional statistically distinct signals for nicotine dependence, tagged by rs578776 and rs588765. One goal of the Consortium for the Genetic Analysis of Smoking Phenotypes (CGASP) is to elucidate the associations among these markers and dichotomous smoking quantity (heavy versus light smoking), lung cancer, and chronic obstructive pulmonary disease (COPD). We performed a meta-analysis across 34 datasets of European-ancestry subjects, including 38,617 smokers who were assessed for cigarettes-per-day, 7,700 lung cancer cases and 5,914 lung-cancer-free controls (all smokers), and 2,614 COPD cases and 3,568 COPD-free controls (all smokers). We demonstrate statistically independent associations of rs16969968 and rs588765 with smoking (mutually adjusted p-values<10(-35) and <10(-8) respectively). Because the risk alleles at these loci are negatively correlated, their association with smoking is stronger in the joint model than when each SNP is analyzed alone. Rs578776 also demonstrates association with smoking after adjustment for rs16969968 (p<10(-6)). In models adjusting for cigarettes-per-day, we confirm the association between rs16969968 and lung cancer (p<10(-20)) and observe a nominally significant association with COPD (p = 0.01); the other loci are not significantly associated with either lung cancer or COPD after adjusting for rs16969968. This study provides strong evidence that multiple statistically distinct loci in this region affect smoking behavior. This study is also the first report of association between rs588765 (and correlates) and smoking that achieves genome-wide significance; these SNPs have previously been associated with mRNA levels of CHRNA5 in brain and lung tissue.
Forest plot for dichotomous CPD at locus 1 (tagging rs16969968).The ORs and 95% CIs are for the effect per allele using additive coding in the logistic regression with age and sex as covariates. The box size indicates the precision of the OR estimate. The case and control totals include only individuals with a genotype call for locus 1. The heterogeneity p-value is 0.21.
Forest plot for dichotomous CPD at locus 2 (tagging rs578776).The ORs and 95% CIs are for the effect per allele using additive coding in the logistic regression with age and sex as covariates. The heterogeneity p-value is 0.69.
Forest plot for dichotomous CPD at locus 3 (tagging rs588765).The ORs and 95% CIs are for the effect per allele using additive coding in the logistic regression with age and sex as covariates. The heterogeneity p-value is 0.59.
Forest plot for lung cancer at locus 1 (tagging rs16969968).The ORs and 95% CIs are for the effect per allele using additive coding in the logistic regression with age, sex and categorical CPD as covariates. The heterogeneity p-value is 0.86.
Forest plot for lung cancer at locus 2 (tagging rs578776).The ORs and 95% CIs are for the effect per allele using additive coding in the logistic regression with age, sex and categorical CPD as covariates. The heterogeneity p-value is 0.44.
Forest plot for lung cancer at locus 3 (tagging rs588765).The ORs and 95% CIs are for the effect per allele using additive coding in the logistic regression with age, sex and categorical CPD as covariates. The heterogeneity p-value is 0.99.
Forest plot for COPD at locus 1 (tagging rs16969968).The ORs and 95% CIs are for the effect per allele using additive coding in the logistic regression with age, sex and categorical CPD as covariates. The heterogeneity p-value is 0.88.
β Prev
41β52 of 52
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2025 | β |
| Comorbidity of lung cancer and chronic obstructive pulmonary disease: correlation and optimization of treatment strategies. | Jiang H et al. | β | 2025 | β |
| The Impact of Smoking-Associated Genetic Variants on Post-Exercise Heart Rate. | Al Ashkar H et al. | β | 2025 | β |
| Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample. | Cinciripini PM et al. | β | 2024 | β |
| Interaction between Continuous Pack-Years Smoked and Polygenic Risk Score on Lung Cancer Risk: Prospective Results from the Framingham Heart Study. | Duncan MS et al. | β | 2024 | β |
| Loci on chromosome 20 interact with rs16969968 to influence cigarettes per day in European ancestry individuals. | Romero Villela PN et al. | β | 2024 | β |
| Single nucleotide variants in lung cancer. | Tian X et al. | β | 2024 | β |
| Smoking-Related Increases in Alcohol Outcomes and Preliminary Evidence for the Protective Effect of a Functional Nicotine Receptor Gene (CHRNA5) Variant on Alcohol Consumption in Individuals Without Alcohol Use Disorder. | Venkatesh SK et al. | β | 2024 | β |
| Targeting Alpha7 Nicotinic Acetylcholine Receptors in Lung Cancer: Insights, Challenges, and Therapeutic Strategies. | Arunrungvichian K et al. | β | 2024 | β |
| Challenges in studying the interplay of genes and environment. A study of childhood financial distress moderating genetic predisposition for peak smoking. | Bierut L et al. | β | 2023 | β |
| Contribution of the Ξ±5 nAChR Subunit and Ξ±5SNP to Nicotine-Induced Proliferation and Migration of Human Cancer Cells. | Papapostolou I et al. | β | 2023 | β |
| Genetic differences between smokers and never-smokers with lung cancer. | KuΕnierczyk P | β | 2023 | β |
| Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment. | Chen LS et al. | β | 2023 | β |
| Hierarchical association of COPD to principal genetic components of biological systems. | Carlin DE et al. | β | 2023 | β |
| Identification of Pathogenic Missense Mutations in the CHRNA5 Gene: A Computational Approach. | Kumaraguru M et al. | β | 2023 | β |
| Association of Polymorphism <i>CHRNA5</i> and <i>CHRNA3</i> Gene in People Addicted to Nicotine. | Chmielowiec K et al. | β | 2022 | β |
| Association of smoking and polygenic risk with the incidence of lung cancer: a prospective cohort study. | Zhang P et al. | β | 2022 | β |
| Downregulation of Stem-Loop Binding Protein by Nicotine via Ξ±7-Nicotinic Acetylcholine Receptor and Its Role in Nicotine-Induced Cell Transformation. | Sun Q et al. | β | 2022 | β |
| Efficient estimation of indirect effects in case-control studies using a unified likelihood framework. | Satten GA et al. | β | 2022 | β |
| Epidemiological evidence for associations between variants in CHRNA genes and risk of lung cancer and chronic obstructive pulmonary disease. | Yang L et al. | β | 2022 | β |
| Examining the role of mitochondrial genetic variation in nicotine dependence. | Giannoulis SV et al. | β | 2022 | β |
| Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma. | Pal K et al. | β | 2022 | β |
| Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. | Rosenberger A et al. | β | 2022 | β |
| Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies. | Liu C et al. | β | 2022 | β |
| Hedgehog-interacting protein acts in the habenula to regulate nicotine intake. | Caligiuri SPB et al. | β | 2022 | β |
| <i>CHRNA5</i> rs16969968 and <i>CHRNA3</i> rs578776 polymorphisms are associated with multiple nicotine dependence phenotypes in Bangladeshi smokers. | Chaity NI et al. | β | 2022 | β |
| Loci on Chromosome 20 Interact with rs16969968 to Influence Cigarettes per Day in European Ancestry Individuals | Ehringer M et al. | β | 2022 | β |
| A Robust Test for Additive Gene-Environment Interaction Under the Trend Effect of Genotype Using an Empirical Bayes-Type Shrinkage Estimator. | Sanyal N et al. | β | 2021 | β |
| Chr15q25 Genetic Variant rs16969968 Alters Cell Differentiation in Respiratory Epithelia. | Diabasana Z et al. | β | 2021 | β |
| Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers. | Hopkins RJ et al. | β | 2021 | β |
| Connecting COPD GWAS Genes: FAM13A Controls TGFΞ²2 Secretion by Modulating AP-3 Transport. | Gong L et al. | β | 2021 | β |
| Dynamic change in the association of a cigarettes-per-day polygenic risk score across the numeric range of its corresponding phenotype over adolescence and young adulthood. | Deutsch AR et al. | β | 2021 | β |
| Effects of tobacco and vaping on the skin. | Mitri A et al. | β | 2021 | β |
| Gene-based association analysis reveals involvement of LAMA5 and cell adhesion pathways in nicotine dependence in African- and European-American samples. | Fan R et al. | β | 2021 | β |
| Genetic Factors Associated with COPD Depend on the Ancestral Caucasian/Amerindian Component in the Mexican Population. | PΓ©rez-Rubio G et al. | β | 2021 | β |
| Genetics of substance use disorders in the era of big data. | Gelernter J et al. | β | 2021 | β |
| Genetic Susceptibility to Pneumonia: A GWAS Meta-Analysis Between the UK Biobank and FinnGen. | Campos AI et al. | β | 2021 | β |
| Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study. | PΓ©rez-Rubio G et al. | β | 2021 | β |
| Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms. | Brynildsen JK et al. | β | 2021 | β |
| Nicotinic acetylcholine gene cluster CHRNA5-A3-B4 variants influence smoking status in a Bangladeshi population. | Chaity NI et al. | β | 2021 | β |
| Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism. | Perez-Paramo YX et al. | β | 2021 | β |
| Proof of Concept of a Personalized Genetic Risk Tool to Promote Smoking Cessation: High Acceptability and Reduced Cigarette Smoking. | Ramsey AT et al. | β | 2021 | β |
| 2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation. | Bierut LJ | β | 2020 | β |
| Comparison of haplotype-based tests for detecting gene-environment interactions with rare variants. | Papachristou C et al. | β | 2020 | β |
| Do Nicotinic Receptors Modulate High-Order Cognitive Processing? | Koukouli F et al. | β | 2020 | β |
| Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. | Chen J et al. | β | 2020 | β |
| Inhaled nicotine and lung cancer: Potential role of the nicotinic acetylcholine receptor. | Young RP et al. | β | 2020 | β |
| Modulation of "Protective" Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-cigarettes. | DeVito EE et al. | β | 2020 | β |
| Participatory Design of a Personalized Genetic Risk Tool to Promote Behavioral Health. | Ramsey AT et al. | β | 2020 | β |
| Reply to Young and Scott: Nicotine and nicotinic acetylcholine receptor mutations in electronic-cigarette smoke lung carcinogenicity. | Tang MS | β | 2020 | β |
| The Influence of Recreational Substance Use in TMS Research. | Turco CV et al. | β | 2020 | β |
| The Role of A Priori-Identified Addiction and Smoking Gene Sets in Smoking Behaviors. | Evans LM et al. | β | 2020 | β |
| Acetylcholine signaling system in progression of lung cancers. | Friedman JR et al. | β | 2019 | β |
| Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls. | Lutz SM et al. | β | 2019 | β |
| Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and AlcoholΒ Use. | Brazel DM et al. | β | 2019 | β |
| Smoking-induced iron dysregulation in the lung. | Zhang WZ et al. | β | 2019 | β |
| A little rein on addiction. | Mathuru AS | β | 2018 | β |
| A novel genetic marker of decreased inflammation and improved survival after acute myocardial infarction. | Coverstone ED et al. | β | 2018 | β |
| Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence. | Lee SH et al. | β | 2018 | β |
| From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. | Salloum NC et al. | β | 2018 | β |
| Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease. | Lang BM et al. | β | 2018 | β |
| Genome-Wide Association Study of Heavy Smoking and Daily/Nondaily Smoking in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). | Saccone NL et al. | β | 2018 | β |
| Informing Prevention and Intervention Policy Using Genetic Studies of Resistance. | Maher BS et al. | β | 2018 | β |
| Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How. | Chen LS et al. | β | 2018 | β |
| Neuroepigenetics and addiction. | Walker DM et al. | β | 2018 | β |
| Pathways to precision medicine in smoking cessation treatments. | Chen LS et al. | β | 2018 | β |
| Preparing the Way: Exploiting Genomic Medicine to Stop Smoking. | Bierut LJ et al. | β | 2018 | β |
| Proper conditional analysis in the presence of missing data: Application to large scale meta-analysis of tobacco use phenotypes. | Jiang Y et al. | β | 2018 | β |
| Statistical Analysis of Multiple Phenotypes in Genetic Epidemiologic Studies: From Cross-Phenotype Associations to Pleiotropy. | Salinas YD et al. | β | 2018 | β |
| Study on polymorphisms in CHRNA5/CHRNA3/CHRNB4 gene cluster and the associated with the risk of non-small cell lung cancer. | Sun Y et al. | β | 2018 | β |
| The role of nicotinic receptor genes (CHRN) in the pathways of prenatal tobacco exposure on smoking behavior among young adult light smokers. | Selya AS et al. | β | 2018 | β |
| The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. | Saccone NL et al. | β | 2018 | β |
| Toward the implementation of genomic applications for smoking cessation and smoking-related diseases. | Ramsey AT et al. | β | 2018 | β |
| Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. | Bozinoff N et al. | β | 2018 | β |
| Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics. | Nedeljkovic I et al. | β | 2018 | β |
| Using imputed genotype data in the joint score tests for genetic association and gene-environment interactions in case-control studies. | Song M et al. | β | 2018 | β |
| A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems. | Richmond-Rakerd LS et al. | β | 2017 | β |
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2017 | β |
| Classification Tree Analysis as a Method for Uncovering Relations Between CHRNA5A3B4 and CHRNB3A6 in Predicting Smoking Progression in Adolescent Smokers. | Pugach O et al. | β | 2017 | β |
| Evaluation of a Novel Difficulty of Smoking Cessation Phenotype Based on Number of Quit Attempts. | Stevens VL et al. | β | 2017 | β |
| Examination of the Involvement of Cholinergic-Associated Genes in Nicotine Behaviors in European and African Americans. | Melroy-Greif WE et al. | β | 2017 | β |
| Genetics of addictive behavior: the example of nicotine dependence. | Gorwood P et al. | β | 2017 | β |
| Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci. | Pintarelli G et al. | β | 2017 | β |
| Genetic variation in the exome: Associations with alcohol and tobacco co-use. | Otto JM et al. | β | 2017 | β |
| Pathways to smoking behaviours: biological insights from the Tobacco and Genetics Consortium meta-analysis. | MinicΓ£ CC et al. | β | 2017 | β |
| Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. | Schuit E et al. | β | 2017 | β |
| Quantifying the Genetic Correlation between Multiple Cancer Types. | LindstrΓΆm S et al. | β | 2017 | β |
| The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations. | Barrie ES et al. | β | 2017 | β |
| The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease. | Cloonan SM et al. | β | 2017 | β |
| Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues. | Zhang B et al. | β | 2017 | β |
| Achieving success with the Research Domain Criteria (RDoC): Going beyond the matrix. | Iacono WG | β | 2016 | β |
| An Adolescent Substance Prevention Model Blocks the Effect of CHRNA5 Genotype on Smoking During High School. | Vandenbergh DJ et al. | β | 2016 | β |
| An efficient method to genotype the polymorphisms of cholinergic nicotinic receptor subunit genes and their associations with COPD onset risk. | Zhao Z et al. | β | 2016 | β |
| A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders. | Jensen KP | β | 2016 | β |
| Association Between CHRNA3 and CHRNA5 Nicotine Receptor Subunit Gene Variants and Nicotine Dependence in an Isolated Populationof Kashubians in Poland. | Kita-Milczarska K et al. | β | 2016 | β |
| Association between two CHRNA3 variants and susceptibility of lung cancer: a meta-analysis. | Qu X et al. | β | 2016 | β |
| Association between variants in nicotinic acetylcholine receptor genes and smoking cessation in a Chinese rural population. | Wang Q et al. | β | 2016 | β |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. | Schwantes-An TH et al. | β | 2016 | β |
| Associations between smoking behavior-related alleles and the risk of melanoma. | Wu W et al. | β | 2016 | β |
| Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal. | Evans DE et al. | β | 2016 | β |
| CHRNA5/A3/B4 Variant rs3743078 and Nicotine-Related Phenotypes: Indirect Effects Through Nicotine Craving. | Shmulewitz D et al. | β | 2016 | β |
| Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males. | Zhang Y et al. | β | 2016 | β |
| Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism. | Wen L et al. | β | 2016 | β |
| Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions. | Yang J et al. | β | 2016 | β |
| Deep Sequencing of Three Loci Implicated in Large-Scale Genome-Wide Association Study Smoking Meta-Analyses. | Clark SL et al. | β | 2016 | β |
| Epidemiology of Lung Cancer. | Schwartz AG et al. | β | 2016 | β |
| Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease. | Hobbs BD et al. | β | 2016 | β |
| Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans. | David SP et al. | β | 2016 | β |
| Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. | Chen LS et al. | β | 2016 | β |
| Genetic scores of smoking behaviour in a Chinese population. | Yang S et al. | β | 2016 | β |
| Genetics of Substance Use Disorders. | Yu C et al. | β | 2016 | β |
| Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers. | HalldΓ©n S et al. | β | 2016 | β |
| Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries. | Baurley JW et al. | β | 2016 | β |
| Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. | Zanetti KA et al. | β | 2016 | β |
| Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2. | Ware JJ et al. | β | 2016 | β |
| How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science. | Jensen KP et al. | β | 2016 | β |
| Meta-Analyses of Genome-Wide Association Data Hold New Promise for Addiction Genetics. | Agrawal A et al. | β | 2016 | β |
| Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. | Cloonan SM et al. | β | 2016 | β |
| Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use. | Melroy-Greif WE et al. | β | 2016 | β |
| Polygenic risk scores for cigarettes smoked per day do not generalize to a Native American population. | Otto JM et al. | β | 2016 | β |
| Risk factors for lung cancer worldwide. | Malhotra J et al. | β | 2016 | β |
| Sharp sensitivity bounds for mediation under unmeasured mediator-outcome confounding. | Ding P et al. | β | 2016 | β |
| SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways. | PΓ©rez-Rubio G et al. | β | 2016 | β |
| The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics. | Lassi G et al. | β | 2016 | β |
| The Oncogenic Functions of Nicotinic Acetylcholine Receptors. | Zhao Y | β | 2016 | β |
| A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans. | Jensen KP et al. | β | 2015 | β |
| A multiancestry study identifies novel genetic associations with CHRNA5 methylation in human brain and risk of nicotine dependence. | Hancock DB et al. | β | 2015 | β |
| An exposure-weighted score test for genetic associations integrating environmental risk factors. | Han SS et al. | β | 2015 | β |
| A powerful nonparametric statistical framework for family-based association analyses. | Li M et al. | β | 2015 | β |
| Association between genetic variants on chromosome 15q25 locus and several nicotine dependence traits in Polish population: a case-control study. | Buczkowski K et al. | β | 2015 | β |
| Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies. | Nishizawa D et al. | β | 2015 | β |
| Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. | Mamoun M et al. | β | 2015 | β |
| CHRNA3 rs6495308 genotype as an effect modifier of the association between daily cigarette consumption and hypertension in Chinese male smokers. | Wu XY et al. | β | 2015 | β |
| CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. | Chen LS et al. | β | 2015 | β |
| Developmental Changes in Genetic and Shared Environmental Contributions to Smoking Initiation and Subsequent Smoking Quantity in Adolescence and Young Adulthood. | Bares CB et al. | β | 2015 | β |
| Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells. | Hoeppner LH et al. | β | 2015 | β |
| Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer. | Yang L et al. | β | 2015 | β |
| Effect of the rs1051730-rs16969968 variant and smoking cessation treatment: a meta-analysis. | Leung T et al. | β | 2015 | β |
| Genetic influences on nicotinic Ξ±5 receptor (CHRNA5) CpG methylation and mRNA expression in brain and adipose tissue. | Ramsay JE et al. | β | 2015 | β |
| Genetic risks to nicotine dependence predict negative mood and affect in current non-smokers. | Chen X et al. | β | 2015 | β |
| Genome-wide association study of nicotine dependence in American populations: identification of novel risk loci in both African-Americans and European-Americans. | Gelernter J et al. | β | 2015 | β |
| Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. | Tyndale RF et al. | β | 2015 | β |
| Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications. | Stoker AK et al. | β | 2015 | β |
| Nicotine dependence in an isolated population of Kashubians from North Poland: a population survey. | Sieminska A et al. | β | 2015 | β |
| Nicotinic receptors in non-human primates: Analysis of genetic and functional conservation with humans. | Shorey-Kendrick LE et al. | β | 2015 | β |
| Return of individual genetic results in a high-risk sample: enthusiasm and positive behavioral change. | Hartz SM et al. | β | 2015 | β |
| Risky Business: Pathways to Progress in Biologically Informed Studies of Psychopathology. | Agrawal A et al. | β | 2015 | β |
| Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases. | ZiΓ³Εkowska-Suchanek I et al. | β | 2015 | β |
| The DRD2/ANKK1 Taq1A polymorphism is associated with smoking cessation failure in patients with coronary heart disease. | Mayer O et al. | β | 2015 | β |
| The role of haplotype in 15q25.1 locus in lung cancer risk: results of scanning chromosome 15. | Ji X et al. | β | 2015 | β |
| The Ξ²3 subunit of the nicotinic acetylcholine receptor: Modulation of gene expression and nicotine consumption. | Kamens HM et al. | β | 2015 | β |
| UBXN2A regulates nicotinic receptor degradation by modulating the E3 ligase activity of CHIP. | Teng Y et al. | β | 2015 | β |
| When Does Choice of Accuracy Measure Alter Imputation Accuracy Assessments? | Ramnarine S et al. | β | 2015 | β |
| Acetylcholine receptor pathway in lung cancer: New twists to an old story. | Niu XM et al. | β | 2014 | β |
| A glimpse into the future - Personalized medicine for smoking cessation. | Bierut LJ et al. | β | 2014 | β |
| Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study. | Park SL et al. | β | 2014 | β |
| Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers. | Zhu AZ et al. | β | 2014 | β |
| Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide. | Bloom AJ et al. | β | 2014 | β |
| CHRNA5 and CHRNA3 variants and level of neuroticism in young adult Mexican American men and women. | Criado JR et al. | β | 2014 | β |
| CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction. | Chen LS et al. | β | 2014 | β |
| CHRNA5 variants moderate the effect of nicotine deprivation on a neural index of cognitive control. | Evans DE et al. | β | 2014 | β |
| Chronic Obstructive Pulmonary Disease Genetics: A Review of the Past and a Look Into the Future. | Hardin M et al. | β | 2014 | β |
| Effect of neuronal nicotinic acetylcholine receptor genes (CHRN) on longitudinal cigarettes per day in adolescents and young adults. | Cannon DS et al. | β | 2014 | β |
| Emphysema genetics. Location, location, location! | Pillai SG | β | 2014 | β |
| Familial aggregation of tobacco use behaviors among Amish men. | Nugent KL et al. | β | 2014 | β |
| Functional characterization improves associations between rare non-synonymous variants in CHRNB4 and smoking behavior. | Haller G et al. | β | 2014 | β |
| Gene-environment dependence creates spurious gene-environment interaction. | Dudbridge F et al. | β | 2014 | β |
| Genetic Association of CHRNB3 and CHRNA6 Gene Polymorphisms with Nicotine Dependence Syndrome Scale in Korean Population. | Won WY et al. | β | 2014 | β |
| Genetics and smoking. | Loukola A et al. | β | 2014 | β |
| Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India. | Anantharaman D et al. | β | 2014 | β |
| Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample. | Loukola A et al. | β | 2014 | β |
| Identification of CHRNA5 rare variants in African-American heavy smokers. | Doyle GA et al. | β | 2014 | β |
| Integrating genetics and social science: genetic risk scores. | Belsky DW et al. | β | 2014 | β |
| Integrative genomics of chronic obstructive pulmonary disease. | Hobbs BD et al. | β | 2014 | β |
| Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction. | Chen LS et al. | β | 2014 | β |
| Introduction to deep sequencing and its application to drug addiction research with a focus on rare variants. | Wang S et al. | β | 2014 | β |
| Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium. | Taylor AE et al. | β | 2014 | β |
| Joint association of nicotinic acetylcholine receptor variants with abdominal obesity in American Indians: the Strong Heart Family Study. | Zhu Y et al. | β | 2014 | β |
| Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability. | Fowler CD et al. | β | 2014 | β |
| Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). | Chen LS et al. | β | 2014 | β |
| Practical barriers and ethical challenges in genetic data sharing. | Simpson CL et al. | β | 2014 | β |
| Protection genes in nucleus accumbens shell affect vulnerability to nicotine self-administration across isogenic strains of adolescent rat. | Chen H et al. | β | 2014 | β |
| Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependence. | Haller G et al. | β | 2014 | β |
| Rare nonsynonymous exonic variants in addiction and behavioral disinhibition. | Vrieze SI et al. | β | 2014 | β |
| Scientific overview: 2013 BBC plenary symposium on tobacco addiction. | De Biasi M et al. | β | 2014 | β |
| Spherical Topic Models for Imaging Phenotype Discovery in Genetic Studies. | Batmanghelich KN et al. | β | 2014 | β |
| Susceptibility loci for lung cancer are associated with mRNA levels of nearby genes in the lung. | Nguyen JD et al. | β | 2014 | β |
| The association between the rs6495309 polymorphism in CHRNA3 gene and lung cancer risk in Chinese: a meta-analysis. | Xiao M et al. | β | 2014 | β |
| The Genetics, Neurogenetics and Pharmacogenetics of Addiction. | Demers CH et al. | β | 2014 | β |
| The relationship between obesity and prescription of smoking cessation medications. | Yu Y et al. | β | 2014 | β |
| Variants near CHRNB3-CHRNA6 are associated with DSM-5 cocaine use disorder: evidence for pleiotropy. | Sadler B et al. | β | 2014 | β |
| Variation in the Ξ± 5 nicotinic acetylcholine receptor subunit gene predicts cigarette smoking intensity as a function of nicotine content. | Macqueen DA et al. | β | 2014 | β |
| A compensatory effect upon splicing results in normal function of the CYP2A6*14 allele. | Bloom AJ et al. | β | 2013 | β |
| A complex interplay between personality domains, marital status and a variant in CHRNA5 on the risks of cocaine, nicotine dependences and cocaine-induced paranoia. | Zayats T et al. | β | 2013 | β |
| A genome-wide association study of behavioral disinhibition. | McGue M et al. | β | 2013 | β |
| Association between a 15q25 gene variant, nicotine-related habits, lung cancer and COPD among 56,307 individuals from the HUNT study in Norway. | Gabrielsen ME et al. | β | 2013 | β |
| Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era. | Brothers JF et al. | β | 2013 | β |
| Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. | Garcia-Closas M et al. | β | 2013 | β |
| Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. | Siedlinski M et al. | β | 2013 | β |
| Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking. | Stephens SH et al. | β | 2013 | β |
| Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations. | Tekpli X et al. | β | 2013 | β |
| Genetic instrumental variable studies of effects of prenatal risk factors. | Wehby GL et al. | β | 2013 | β |
| Genetic linkage analysis identifies Pas1 as the common locus modulating lung tumorigenesis and acute inflammatory response in mice. | Galvan A et al. | β | 2013 | β |
| Genetic risk for nicotine dependence in the cholinergic system and activation of the brain reward system in healthy adolescents. | Nees F et al. | β | 2013 | β |
| Genetic susceptibility to lung cancer and co-morbidities. | Yang IA et al. | β | 2013 | β |
| Genome-wide association analysis for multiple continuous secondary phenotypes. | Schifano ED et al. | β | 2013 | β |
| Genomics and personalized medicine: <i>CHRNA5-CHRNA3-CHRNB4</i> and smoking cessation treatment. | Chen LS et al. | β | 2013 | β |
| Interpreting joint SNP analysis results: when are two distinct signals really two distinct signals? | Schwantes-An TH et al. | β | 2013 | β |
| Joint associations of 61 genetic variants in the nicotinic acetylcholine receptor genes with subclinical atherosclerosis in American Indians: a gene-family analysis. | Yang J et al. | β | 2013 | β |
| Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma. | Falvella FS et al. | β | 2013 | β |
| Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence. | Hendrickson LM et al. | β | 2013 | β |
| Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. | Bergen AW et al. | β | 2013 | β |
| Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. | Wassenaar CA et al. | β | 2013 | β |
| Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. | Belsky DW et al. | β | 2013 | β |
| Protocol for a collaborative meta-analysis of 5-HTTLPR, stress, and depression. | Culverhouse RC et al. | β | 2013 | β |
| Scrutiny of the CHRNA5-CHRNA3-CHRNB4 smoking behavior locus reveals a novel association with alcohol use in a Finnish population based study. | HΓ€llfors J et al. | β | 2013 | β |
| Smoking and psychopathology increasingly associated in recent birth cohorts. | Talati A et al. | β | 2013 | β |
| The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers. | Robinson JD et al. | β | 2013 | β |
| Unraveling the neurobiology of nicotine dependence using genetically engineered mice. | Stoker AK et al. | β | 2013 | β |
| A flexible Bayesian model for studying gene-environment interaction. | Yu K et al. | β | 2012 | β |
| A gene-based test of association using canonical correlation analysis. | Tang CS et al. | β | 2012 | β |
| A gene-family analysis of 61 genetic variants in the nicotinic acetylcholine receptor genes for insulin resistance and type 2 diabetes in American Indians. | Yang J et al. | β | 2012 | β |
| A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. | Cho MH et al. | β | 2012 | β |
| Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort. | Bousman CA et al. | β | 2012 | β |
| Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4 gene cluster association with several nicotine dependence traits. | Broms U et al. | β | 2012 | β |
| Assessing the impact of nicotine dependence genes on the risk of facial clefts: An example of the use of national registry and biobank data. | Jugessur A et al. | β | 2012 | β |
| Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population. | Zhou H et al. | β | 2012 | β |
| Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue. | Fehringer G et al. | β | 2012 | β |
| Associations between variation in CHRNA5-CHRNA3-CHRNB4, body mass index and blood pressure in the Northern Finland Birth Cohort 1966. | Kaakinen M et al. | β | 2012 | β |
| CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland. | Hardin M et al. | β | 2012 | β |
| CHRNA3 genotype, nicotine dependence, lung function and disease in the general population. | Kaur-Knudsen D et al. | β | 2012 | β |
| CHRNB3 is more strongly associated with FagerstrΓΆm test for cigarette dependence-based nicotine dependence than cigarettes per day: phenotype definition changes genome-wide association studies results. | Rice JP et al. | β | 2012 | β |
| Cocaine and nicotine research illustrates a range of hypocretin mechanisms in addiction. | Baimel C et al. | β | 2012 | β |
| Connecting ncRNA Cigarette Smoking Studies with Tobacco Use Behaviors and Health Outcomes. | Ehringer MA | β | 2012 | β |
| Deficiency of the odds ratio for common outcomes. | Kaufman JS et al. | β | 2012 | β |
| Externalizing behaviors are associated with SNPs in the CHRNA5/CHRNA3/CHRNB4 gene cluster. | Stephens SH et al. | β | 2012 | β |
| From men to mice: CHRNA5/CHRNA3, smoking behavior and disease. | Ware JJ et al. | β | 2012 | β |
| Functional polymorphisms of CHRNA3 predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese. | Yang L et al. | β | 2012 | β |
| Genes and chronic obstructive pulmonary disease. | Foreman MG et al. | β | 2012 | β |
| Genetic architectures of psychiatric disorders: the emerging picture and its implications. | Sullivan PF et al. | β | 2012 | β |
| Genetic epidemiology of cigarette smoke-induced lung disease. | Schwartz AG | β | 2012 | β |
| Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. | de Andrade M et al. | β | 2012 | β |
| Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. | VanderWeele TJ et al. | β | 2012 | β |
| Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. | Wilk JB et al. | β | 2012 | β |
| Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. | Hartz SM et al. | β | 2012 | β |
| Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. | Timofeeva MN et al. | β | 2012 | β |
| Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. | Chen LS et al. | β | 2012 | β |
| Lung carcinogenesis by tobacco smoke. | Hecht SS | β | 2012 | β |
| Measuring alcohol consumption for genomic meta-analyses of alcohol intake: opportunities and challenges. | Agrawal A et al. | β | 2012 | β |
| Nicotine dependence and comorbid psychiatric disorders: examination of specific genetic variants in the CHRNA5-A3-B4 nicotinic receptor genes. | Chen LS et al. | β | 2012 | β |
| Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence. | Haller G et al. | β | 2012 | β |
| Recent advances in the genetic epidemiology and molecular genetics of substance use disorders. | Kendler KS et al. | β | 2012 | β |
| Response to Kaufman and Harper letter. | Chen LS et al. | β | 2012 | β |
| Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. | Chen LS et al. | β | 2012 | β |
| Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. | King DP et al. | β | 2012 | β |
| The CHRNA5/A3/B4 gene cluster and tobacco, alcohol, cannabis, inhalants and other substance use initiation: replication and new findings using mixture analyses. | Lubke GH et al. | β | 2012 | β |
| The CHRNA5-A3-B4 gene cluster in nicotine addiction. | Berrettini WH et al. | β | 2012 | β |
| The genetics of addiction-a translational perspective. | Agrawal A et al. | β | 2012 | β |
| The genetics of substance dependence. | Wang JC et al. | β | 2012 | β |
| Translational genetic approaches to substance use disorders: bridging the gap between mice and humans. | Palmer AA et al. | β | 2012 | β |
| Updates on the COPD gene list. | BossΓ© Y | β | 2012 | β |
| Variants located upstream of CHRNB4 on chromosome 15q25.1 are associated with age at onset of daily smoking and habitual smoking. | Kapoor M et al. | β | 2012 | β |
| A quantitative-trait genome-wide association study of alcoholism risk in the community: findings and implications. | Heath AC et al. | β | 2011 | β |
| Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis. | Ware JJ et al. | β | 2011 | β |
| Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. | Falcone M et al. | β | 2011 | β |
| A twin association study of nicotine dependence with markers in the CHRNA3 and CHRNA5 genes. | Maes HH et al. | β | 2011 | β |
| Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk. | Wang Y et al. | β | 2011 | β |
| Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer. | Grose D et al. | β | 2011 | β |
| Developmental perspective on the role of genes in smoking risk. | Gelernter J | β | 2011 | β |
| Functional characterization of the Ξ±5(Asn398) variant associated with risk for nicotine dependence in the Ξ±3Ξ²4Ξ±5 nicotinic receptor. | Li P et al. | β | 2011 | β |
| GENES AS INSTRUMENTS FOR STUDYING RISK BEHAVIOR EFFECTS: AN APPLICATION TO MATERNAL SMOKING AND OROFACIAL CLEFTS. | Wehby G et al. | β | 2011 | β |
| Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. | Timofeeva MN et al. | β | 2011 | β |
| Genetics of sputum gene expression in chronic obstructive pulmonary disease. | Qiu W et al. | β | 2011 | β |
| Genetic vulnerability and susceptibility to substance dependence. | Bierut LJ | β | 2011 | β |
| Genome-wide association studies of alcohol dependence and substance use disorders. | Treutlein J et al. | β | 2011 | β |
| Genome-wide association study of smoking behaviours in patients with COPD. | Siedlinski M et al. | β | 2011 | β |
| Individualized smoking cessation treatment: roles for sets of genomic markers. | Uhl GR et al. | β | 2011 | β |
| In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. | Doyle GA et al. | β | 2011 | β |
| Nicotinic acetylcholine receptor variants associated with susceptibility to chronic obstructive pulmonary disease: a meta-analysis. | Zhang J et al. | β | 2011 | β |
| Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. | Jaworowska E et al. | β | 2011 | β |
| The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence. | Jackson KJ et al. | β | 2011 | β |
| Uncovering hidden variance: pair-wise SNP analysis accounts for additional variance in nicotine dependence. | Culverhouse RC et al. | β | 2011 | β |
| Update in lung cancer and oncological disorders 2010. | Halmos B et al. | β | 2011 | β |
| Multi-locus test conditional on confirmed effects leads to increased power in genome-wide association studies. | Ma L et al. | β | 2010 | β |
| Neurocognitive phenotypes and genetic dissection of disorders of brain and behavior. | Congdon E et al. | β | 2010 | β |
| The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome. | Mackillop J et al. | β | 2010 | β |